Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Earnings for Alembic Pharmaceuticals Limited (APLLTD.NS)
Earnings in 2023 (TTM): $75.31 M
According to Alembic Pharmaceuticals Limited's latest financial reports the company's current earnings (TTM) are $75.31 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Alembic Pharmaceuticals Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $75.31 M | $73.29 M |
| 2022 | $42.2 M | $40.7 M |
| 2021 | $73.8 M | $62 M |
| 2020 | $162.81 M | $136.44 M |
| 2019 | $118.98 M | $98.63 M |
| 2018 | $89.17 M | $69.54 M |
| 2017 | $64.41 M | $49.11 M |
| 2016 | $62.52 M | $47.98 M |
| 2015 | $111.34 M | $85.62 M |
| 2014 | $42.73 M | $33.67 M |
| 2013 | $36.96 M | $28.03 M |
| 2012 | $24.56 M | $19.67 M |
| 2011 | $19.16 M | $15.49 M |
| 2010 | $12.72 M | $10.16 M |